TGFB1 and coronary artery disorder: Importantly, key components and downstream effectors of TGF-β signaling were upregulated in TOF patients and negatively correlated with RNF20 expression, suggesting that targeting the RNF20-TGF-β axis may offer therapeutic benefit for patients with cyanotic CHD patients.